Abstract
The ideal goal of a screening program for breast cancer is to detect the disease at a stage when it is still curable by a simple lumpectomy. This goal would be possible if the tumor had an early latent period before it was vascularized. However, even if there existed a harmless screening examination that was sensitive enough to discover the cancer at this stage the benefit to be gained from a screening program would be highly dependent on the time the tumor spends in the latent stage as well as on the chance of false negatives at the examination. Calculations derived from a mathematical model suggest a variety of theoretically possible situations including: (1) For certain cancers screening every three years would offer almost as much benefit as screening every year; (2) A large increase in the sensitivity of a screening examination does not necessarily lead to a large increase in the benefit of a screening program; (3) For certain cancers the benefit of screening might remain low no matter how sensitive the examination used.
Similar content being viewed by others
References
Blumenson, L. E.: 1977, ‘Detection of disease with periodic screening: Transient analysis and application to mammography examination’,Mathematical Biosciences 33, 73–106.
Blumenson, L. E., Bross, I. D. J.: 1969, ‘A mathematical analysis of the growth and spread of breast cancer’,Biometrics 25, 95–109.
Brem, S., Brem, H., Folkman, J., et al.: 1976, ‘Prolonged tumor dormancy by prevention of neovascularization in the vitreous’,Cancer Research 36, 2807–2812.
Brem, S., Jensen, H., and Gullino, P.: 1978, ‘Angiogenesis as a marker of preneoplastic lesions of the human breast’,Cancer 41, 239–244.
Fox, M. S.: 1979, ‘On the diagnosis and treatment of breast cancer’,Journal of the American Medical Association 241, 489–494.
Kusama, S., Spratt, J. S., Donegan, W. L., et al.: 1972, ‘The gross rates of growth of human mammary carcinoma’.Cancer 30, 594–599.
Moskowitz, M. S.: 1979, ‘Breast cancer detection and treatment revisited’,Journal of the American Medical Association 242, 1037–1038.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blumenson, L.E. How would a latent period for early breast cancer affect the benefit of screening?. Metamedicine 2, 169–182 (1981). https://doi.org/10.1007/BF00884421
Issue Date:
DOI: https://doi.org/10.1007/BF00884421